Skip to search formSkip to main contentSkip to account menu

SN30000

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Introduction: Chemotherapy is often limited by resistant subpopulations of tumor cells. Tumor hypoxia contributes to resistance… 
2014
2014
Triple-negative breast cancer (TNBC) is an aggressive malignancy with poor clinical outcome and few validated drug targets. Two… 
2013
2013
Background: NADPH:cytochrome P450 oxidoreductase (POR) catalyzes one-electron reduction of hypoxia-activated prodrugs (HAP… 
2012
2012
Hypoxia is more severe in tumors than normal tissues, and contributes to tumor progression and therapeutic resistance. It is… 
2011
2011
e13597 Background: SN30000 (CEN-209), a benzotriazine-N-oxide, is a second generation analogue of tirapazamine (TPZ) and is… 
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Introduction: SN30000 (CEN-209) is a structural…